Transoral Incisionless Fundoplication (TIF) for Treatment of GERD
Customize your policy alerts
Sign up for Presbyterian Health Plan Policy 20.12 alerts
Get alerted when Policy 20.12 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of transoral incisionless fundoplication, including use of the EsophyX system, for treatment of gastroesophageal reflux disease. Coverage varies by benefit plan and line of business and is subject to applicable coverage guidelines.
TIF using EsophyX is considered medically necessary for patients age 18 and older.
CPT 43210 no longer has an Investigational and Experimental designation for non-Medicare lines of business.
Other endoscopic GERD treatment approaches using CPT 43257, 43499, 43999, or 49999 remain non-covered or unproven.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.